18-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1137 20 1044 83 1011 166 1011
ERLYTX 73 2 104 5 61 8 49
GI 159 1 52 13 158 28 170
GU 402 14 730 52 633 95 578
LEUK 163 6 313 14 170 30 183
LUNG 206 4 209 15 183 25 152
LYMPH 425 8 417 32 390 68 414
MELAN 8 0 0 1 12 1 6
MMYEL 115 2 104 12 146 22 134
MULT 48 0 0 2 24 3 18
OTHER 44 1 52 2 24 3 18
Total 2780 58 3025 231 2812 449 2733

18-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 216 7 365 20 244 39 237
ERLYTX 2 0 0 0 0 0 0
GI 1 0 0 0 0 0 0
GU 5 0 0 1 12 3 18
LEUK 618 19 991 59 718 110 670
LUNG 366 5 261 41 499 66 402
LYMPH 1 0 0 1 12 1 6
OTHER 16 1 52 1 12 5 30
PEOLC 59 0 0 3 37 3 18
PREV 231 5 261 20 244 29 177
SXQOL 650 5 261 43 524 94 572
Total 2165 42 2191 189 2302 350 2130

18-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1137 20 1044 83 1011 166 1011
CCD 216 7 365 20 244 39 237
ERLYTX 75 2 104 5 61 8 49
GI 160 1 52 13 158 28 170
GU 407 14 730 53 645 98 597
LEUK 781 25 1304 73 889 140 852
LUNG 572 9 470 56 682 91 554
LYMPH 426 8 417 33 402 69 420
MELAN 8 0 0 1 12 1 6
MMYEL 115 2 104 12 146 22 134
MULT 48 0 0 2 24 3 18
OTHER 60 2 104 3 37 8 49
PEOLC 59 0 0 3 37 3 18
PREV 231 5 261 20 244 29 177
SXQOL 650 5 261 43 524 94 572
Total 4945 100 5216 420 5116 799 4864

18-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 698 16 835 55 670 96 584
ERLYTX 53 2 104 5 61 7 43
GI 123 1 52 9 110 23 140
GU 296 11 574 36 438 66 402
LEUK 101 4 209 6 73 14 85
LUNG 130 3 157 9 110 18 110
LYMPH 278 4 209 20 244 44 268
MELAN 8 0 0 1 12 1 6
MMYEL 65 1 52 9 110 13 79
MULT 19 0 0 2 24 2 12
OTHER 44 1 52 2 24 3 18
Total 1815 43 2244 154 1876 287 1747

18-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 158 5 261 12 146 28 170
ERLYTX 2 0 0 0 0 0 0
GI 1 0 0 0 0 0 0
GU 5 0 0 1 12 3 18
LEUK 249 6 313 22 268 38 231
LUNG 224 4 209 28 341 45 274
LYMPH 1 0 0 1 12 1 6
OTHER 16 1 52 1 12 5 30
PEOLC 50 0 0 3 37 3 18
PREV 231 5 261 20 244 29 177
SXQOL 474 5 261 34 414 69 420
Total 1411 26 1357 122 1486 221 1344

18-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 893 17 887 71 864 140 852
CCD 171 5 261 11 134 23 140
ERLYTX 55 2 104 5 61 7 43
GI 137 2 104 12 146 30 183
GU 331 9 470 35 426 69 420
LEUK 353 10 522 28 341 52 317
LUNG 387 10 522 40 487 73 444
LYMPH 279 4 209 21 256 45 274
MELAN 8 0 0 1 12 1 6
MMYEL 65 1 52 9 110 13 79
MULT 42 0 0 4 49 8 49
OTHER 125 2 104 3 37 8 49
PEOLC 52 1 52 3 37 4 24
PREV 231 5 261 20 244 29 177
SXQOL 474 5 261 34 414 69 420
Total 3603 73 3809 297 3618 571 3477

18-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 985 20 1044 79 962 158 962
ERLYTX 70 2 104 5 61 8 49
GI 93 0 0 9 110 17 103
GU 295 13 678 44 536 71 432
LEUK 134 6 313 14 170 27 164
LUNG 180 1 52 12 146 21 128
LYMPH 352 8 417 31 377 62 377
MMYEL 102 2 104 11 134 21 128
MULT 48 0 0 2 24 3 18
Total 2259 52 2712 207 2520 388 2361

18-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1885 41 2139 160 1948 300 1826
AFFIL 124 1 52 4 49 8 49
CCOP/NCORP 1217 27 1409 112 1364 200 1218
Non-SWOG 1718 30 1565 143 1741 290 1765
Total 4944 99 5165 419 5102 798 4858

18-OCT-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LEUK S2507 ALL/ALAL, KMT2A-trans, Blina +/- Revumenib 1 Y 22-SEP-26

18-OCT-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
OTHER NRGGY026 Endomet, Stage I-IV, Pac/Car w/ HER HYL/PHE 1 E 29-SEP-26
OTHER NRGBN003 Mening, Grd II, Observation vs Irradiation 1 E 28-SEP-26
OTHER NRGBN003 Mening, Grd II, Observation vs Irradiation 2 E 28-SEP-26
SXQOL NRG-CC013 HN Squamous Cell, Rec Chemo, BMX 1 E 23-SEP-26
LUNG S1900J MET Amplification: Amivantamab Hyaluronidase 1 N 15-OCT-26
OTHER NRGHN009 HN, RT + HD Cisp vs RT + LD Cisp for SCCHN 1 E 02-OCT-26

18-OCT-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 19
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 14
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 9
LUNG LUNGMAP NSCLC, Adv, Master 2 7
MMYEL S1803 MM, Maintenance, Len vs Len/Dara 3 6
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 6
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 6
LUNG LUNGMAP NSCLC, Adv, Master 1 5
PREV NRGCC005 Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs 1 5
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 3 4
LUNG S2409 ESCLC, Durvalumab +/- Biomarker Directed Tx 1 4
CCD S2417CD Colrec Surv, Follow-up w/ CTAC site 1 4
GU S2419 Renal, adv clear cell, IO +/- Biotx, BIOFRONT 1 4
GU S2427 Blad, MIBC, RT + Pembrolizumab 1 4
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 3
CCD S2424CD A-PACT vs SOC for GOC communication 1 3